Positron emission tomography with computed tomography-based diagnosis of massive extramedullary progression in a patient with high-risk multiple myeloma

Clin Lymphoma Myeloma Leuk. 2014 Jun;14(3):e101-4. doi: 10.1016/j.clml.2013.12.014. Epub 2013 Dec 26.

Affiliations

¹ "Seràgnoli" Institute of Hematology, Bologna University School of Medicine, Bologna, Italy. Electronic address: [email protected].
² Institute of Nuclear Medicine, Bologna University School of Medicine, Bologna, Italy.
³ "Seràgnoli" Institute of Hematology, Bologna University School of Medicine, Bologna, Italy.

PMID: 24508412
DOI: 10.1016/j.clml.2013.12.014

No abstract available

Keywords: Extramedullary disease; Multiple myeloma; Novel agents; PET/CT; Prognosis.

Publication types

Case Reports

MeSH terms

Aged
Fatal Outcome
Fluorodeoxyglucose F18
Humans
Male
Multiple Myeloma / diagnosis*
Multiple Myeloma / drug therapy
Multiple Myeloma / pathology
Neoplasm Staging
Positron-Emission Tomography*
Tomography, X-Ray Computed*

Substances

Fluorodeoxyglucose F18